BusinessPostCorner.com
No Result
View All Result
Tuesday, June 17, 2025
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
BusinessPostCorner.com
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources
No Result
View All Result
BusinessPostCorner.com
No Result
View All Result

FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy

November 8, 2023
in Business
Reading Time: 1 min read
A A
0
FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy
ShareShareShareShareShare

Eli Lilly’s diabetes drug tirzepatide gained US approval for treating patients with obesity under a new name, Zepbound, unlocking blockbuster sales potential in a market that’s expected to hit $100 billion by 2030. 

“In light of increasing rates of both obesity and overweight in the United States, today’s approval addresses an unmet medical need,” the US Food and Drug Administration said in a statement Wednesday. 

In a statement, the company said the drug would be sold at a slight premium to the price of the diabetes version of the same medication, sold as Mounjaro. The weight-loss drug will list for $1,059.87 for a month’s supply. It will be available by year end. 

Lilly’s shares rose less than 1% at 12:33 p.m. in New York. They have gained 64% so far this year as of Tuesday’s close. 

The weight-loss drug frenzy has boosted Lilly and Novo Nordisk A/S, and sent shockwaves through unexpected corners of the market. Lilly is now the most valuable health-care company in the world, while Novo, the maker of Ozempic and Wegovy, took the title of Europe’s most valuable company in September.  

Zepbound can cause side effects such as nausea, diarrhea, vomiting, constipation and abdominal pain, the FDA said in a statement.

Subscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team. Sign up for free today.

Credit: Source link

ShareTweetSendPinShare
Previous Post

Long Road To Current Battles

Next Post

Turkey clashes with EU over stance on Hamas

Next Post
Turkey clashes with EU over stance on Hamas

Turkey clashes with EU over stance on Hamas

Is worker loneliness HR’s next big wellness challenge?

Is worker loneliness HR’s next big wellness challenge?

June 16, 2025
Israel is achieving its goals in Iran — so far

Israel is achieving its goals in Iran — so far

June 15, 2025
‘It was sold as a dream but became a nightmare’

‘It was sold as a dream but became a nightmare’

June 16, 2025
Reeves vows to shield UK from Israel-Iran price shock

Reeves vows to shield UK from Israel-Iran price shock

June 15, 2025
Blockchain Adoption Hits 60% of Fortune 500 as SMB Stablecoin Demand Soars

Blockchain Adoption Hits 60% of Fortune 500 as SMB Stablecoin Demand Soars

June 10, 2025
What it takes to lead through volatility and uncertainty

What it takes to lead through volatility and uncertainty

June 13, 2025
BusinessPostCorner.com

BusinessPostCorner.com is an online news portal that aims to share the latest news about following topics: Accounting, Tax, Business, Finance, Crypto, Management, Human resources and Marketing. Feel free to get in touch with us!

Recent News

Binance Leads in Altcoin and Stablecoin Deposits Across ETH and TRON: CryptoQuant

Binance Leads in Altcoin and Stablecoin Deposits Across ETH and TRON: CryptoQuant

June 17, 2025
How climate change could worsen a dangerous sleep condition and cost the global economy billions of dollars in lost productivity

How climate change could worsen a dangerous sleep condition and cost the global economy billions of dollars in lost productivity

June 17, 2025

Our Newsletter!

Loading
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2023 businesspostcorner.com - All Rights Reserved!

No Result
View All Result
  • Home
  • Business
  • Finance
  • Accounting
  • Tax
  • Management
  • Marketing
  • Crypto News
  • Human Resources

© 2023 businesspostcorner.com - All Rights Reserved!